Do we have to reassess classical risk predictors in patients with congestive heart failure since initiation of β-blocker treatment?

The aim of the present study was to evaluate the prognostic value of classical risk factors in chronic heart failure (CHF) since introduction of routine β-blocker treatment in CHF.

Saved in:

Bibliographic Details
Main Authors:	Zugck, Christian (Author) , Kell, Robert (Author) , Kirschke, Andreas Erich (Author) , Schellberg, Dieter (Author) , Loßnitzer, Dirk (Author) , Haass, Markus (Author) , Haunstetter, Armin (Author)
Format:	Article (Journal)
Language:	English
Published:	01 September 2001
In:	European heart journal Year: 2001, Volume: 22, Pages: 300
ISSN:	1522-9645
DOI:	10.1093/eurheartj/22.Abstract_Supplement.1
Online Access:	Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1093/eurheartj/22.Abstract_Supplement.1 Verlag, lizenzpflichtig, Volltext: https://academic.oup.com/eurheartj/article/22/Abstract_Supplement/1/466328 Verlag, lizenzpflichtig, Volltext: https://academic.oup.com/eurheartj/article-pdf/22/Abstract_Supplement/1/1265128/22-Abstract_Supplement-1.pdf
Author Notes:	C. Zugck, R. Kell, A. Kirschke, D. Schellberg, D. Lossnitzer, M. Haass, A. Haunstetter

Description
Summary:	The aim of the present study was to evaluate the prognostic value of classical risk factors in chronic heart failure (CHF) since introduction of routine β-blocker treatment in CHF.
Item Description:	Gesehen am 12.05.2021
Physical Description:	Online Resource
ISSN:	1522-9645
DOI:	10.1093/eurheartj/22.Abstract_Supplement.1